SERA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

40.00K

+66.67%

-0.200

-20%

85.00K

+123.68%

-0.180

-10%

80.00K

+370.59%

-0.190

+18.75%

Estimates Revision

The market is revising No Change the revenue expectations for Sera Prognostics, Inc. (SERA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 20.59%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+20.59%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Sera Prognostics Inc (SERA.O) is -4.11, compared to its 5-year average forward P/E of -4.48. For a more detailed relative valuation and DCF analysis to assess Sera Prognostics Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-4.48

Current PE

-4.11

Overvalued PE

-1.43

Undervalued PE

-7.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-2.12

Current EV/EBITDA

-0.47

Overvalued EV/EBITDA

1.56

Undervalued EV/EBITDA

-5.81

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

215.12

Current PS

168.61

Overvalued PS

461.81

Undervalued PS

-31.58

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 722.23% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 722.23% over the last month.

Sold

Bought

SERA News & Events

Events Timeline

No data

News

3.5

01-07PRnewswire

Sera Prognostics Launches New Blood Test Significantly Reducing Preterm Birth Risk

2.0

2025-12-30NASDAQ.COM

Biotech Stocks Decline, Sera Prognostics Falls 10.1%

4.0

2025-12-21NASDAQ.COM

Sera Prognostics (SERA) Price Target Raised by 81.82% to $5.10

People Also Watch

Frequently Asked Questions

What is Sera Prognostics Inc (SERA) stock price today?

The current price of SERA is 3.69 USD — it has increased 4.53 % in the last trading day.

What is Sera Prognostics Inc (SERA)'s business?

Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

What is the price predicton of SERA Stock?

Wall Street analysts forecast SERA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SERA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Sera Prognostics Inc (SERA)'s revenue for the last quarter?

Sera Prognostics Inc revenue for the last quarter amounts to 16.00K USD, decreased -44.83 % YoY.

What is Sera Prognostics Inc (SERA)'s earnings per share (EPS) for the last quarter?

Sera Prognostics Inc. EPS for the last quarter amounts to -0.16 USD, decreased -33.33 % YoY.

What changes have occurred in the market's expectations for Sera Prognostics Inc (SERA)'s fundamentals?

How many employees does Sera Prognostics Inc (SERA). have?

Sera Prognostics Inc (SERA) has 63 emplpoyees as of January 10 2026.

What is Sera Prognostics Inc (SERA) market cap?

Today SERA has the market capitalization of 142.41M USD.